Evidence map›Paper›PMID 30987231›Full record

ArticleInternational journal of molecular sciences2019

Serial Femtosecond X-Ray Diffraction of HIV-1 Gag MA-IP6 Microcrystals at Ambient Temperature.

Halil I Ciftci, Raymond G Sierra, Chun Hong Yoon, Zhen Su, Hiroshi Tateishi, Ryoko Koga, Koiwai Kotaro, Fumiaki Yumoto, Toshiya Senda, Mengling Liang and 4 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Gamma-aminobutyric acid for delaying type 1 diabetes mellitus: an update.Annals of pediatric endocrinology & metabolism · 2024
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. The XFEL Protein Crystallography: Developments and Perspectives.International journal of molecular sciences · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Halil I CiftciDepartment of Drug Discovery, Science Farm Ltd., Kumamoto 862-0976, Japan. hiciftci@scifarmltd.com.ORCID 0000-0002-9796-7669
Raymond G SierraLinac Coherent Light Source, SLAC National Accelerator Laboratory, Menlo Park, CA 94025, USA. rsierra@slac.stanford.edu.ORCID 0000-0002-6253-8282
Chun Hong YoonLinac Coherent Light Source, SLAC National Accelerator Laboratory, Menlo Park, CA 94025, USA. chuckyoon@stanford.edu.
Zhen SuLinac Coherent Light Source, SLAC National Accelerator Laboratory, Menlo Park, CA 94025, USA. zhensu@stanford.edu.
Hiroshi TateishiDepartment of Bioorganic Medicinal Chemistry, School of Pharmacy, Kumamoto University, Kumamoto 862-0973, Japan. 133y1020@gmail.com.
Ryoko KogaDepartment of Bioorganic Medicinal Chemistry, School of Pharmacy, Kumamoto University, Kumamoto 862-0973, Japan. kk1205@kumamoto-u.ac.jp.
Koiwai KotaroStructural Biology Research Center, Institute of Materials Structure Science, KEK/High Energy Accelerator Research Organization, Tsukuba, Ibaraki 305-0034, Japan. koiwaiko@post.kek.jp.
Fumiaki YumotoStructural Biology Research Center, Institute of Materials Structure Science, KEK/High Energy Accelerator Research Organization, Tsukuba, Ibaraki 305-0034, Japan. Fumiaki.Yumoto@kek.jp.ORCID 0000-0002-9592-397X
Toshiya SendaStructural Biology Research Center, Institute of Materials Structure Science, KEK/High Energy Accelerator Research Organization, Tsukuba, Ibaraki 305-0034, Japan. toshiya.senda@kek.jp.
Mengling LiangLinac Coherent Light Source, SLAC National Accelerator Laboratory, Menlo Park, CA 94025, USA. mliang@slac.stanford.edu.
Soichi WakatsukiBiosciences Division, SLAC National Accelerator Laboratory, Menlo Park, CA 94025, USA. soichi.wakatsuki@stanford.edu.
Masami OtsukaDepartment of Bioorganic Medicinal Chemistry, School of Pharmacy, Kumamoto University, Kumamoto 862-0973, Japan. motsuka@gpo.kumamoto-u.ac.jp.
Mikako FujitaResearch Institute for Drug Discovery, School of Pharmacy, Kumamoto University, Kumamoto 862-0973, Japan. mfujita@kumamoto-u.ac.jp.
Hasan DeMirciStanford PULSE Institute, SLAC National Accelerator Laboratory, Menlo Park, CA 94025, USA. Hasan_DeMirci@stanford.edu.ORCID 0000-0002-9135-5397
SLAC National Accelerator Laboratory · USKumamoto University · JPHigh Energy Accelerator Research Organization · JP

Funding

ZWITTERION SURFACTANT DDMAB FOR IMPROV STABIL OF PROTEINP41RR001209 · NCRR · STANFORD UNIVERSITY · PI SCOTT, EMILY E · 1985 to 2011
$38.9M
X-ray Absorption Spectroscopy (XAS) pp.711-759P41GM103393 · NIGMS · STANFORD UNIVERSITY · PI HODGSON, KEITH O · 2012 to 2019
$30.6M
National Science Foundation 1231306NCRR NIH HHS P41 RR001209NIGMS NIH HHS P41 GM103393
6 · The paper itself

Abstract

The Human immunodeficiency virus-1 (HIV-1) matrix (MA) domain is involved in the highly regulated assembly process of the virus particles that occur at the host cell's plasma membrane. High-resolution structures of the MA domain determined using cryo X-ray crystallography have provided initial insights into the possible steps in the viral assembly process. However, these structural studies have relied on large and frozen crystals in order to reduce radiation damage caused by the intense X-rays. Here, we report the first X-ray free-electron laser (XFEL) study of the HIV-1 MA domain's interaction with inositol hexaphosphate (IP6), a phospholipid headgroup mimic. We also describe the purification, characterization and microcrystallization of two MA crystal forms obtained in the presence of IP6. In addition, we describe the capabilities of serial femtosecond X-ray crystallography (SFX) using an XFEL to elucidate the diffraction data of MA-IP6 complex microcrystals in liquid suspension at ambient temperature. Two different microcrystal forms of the MA-IP6 complex both diffracted to beyond 3.5 Å resolution, demonstrating the feasibility of using SFX to study the complexes of MA domain of HIV-1 Gag polyprotein with IP6 at near-physiological temperatures. Further optimization of the experimental and data analysis procedures will lead to better understanding of the MA domain of HIV-1 Gag and IP6 interaction at high resolution and will provide basis for optimization of the lead compounds for efficient inhibition of the Gag protein recruitment to the plasma membrane prior to virion formation.

Indexed as

TemperatureX-Ray DiffractionCrystallizationgag Gene Products, Human Immunodeficiency VirusHIV-1Models, MolecularProtein DomainsTime FactorsViriongag Gene Products, Human Immunodeficiency Virusambient temperaturehuman immunodeficiency virusinositol hexaphosphatematrix proteinSerial Femtosecond X-ray crystallography

Identifiers

PMID30987231
PMCPMC6479536
OpenAlexW2915395464

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.